These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2137808)

  • 1. Hepatocyte growth factor in fulminant hepatic failure.
    Hughes RD; Gove CD; Williams R
    Hepatology; 1990 Feb; 11(2):332-3. PubMed ID: 2137808
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure.
    Tomiya T; Nagoshi S; Fujiwara K
    Hepatology; 1992 Jan; 15(1):1-4. PubMed ID: 1530786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic expression of hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure.
    Harrison P; Degen SJ; Williams R; Farzaneh F
    Lancet; 1994 Jul; 344(8914):27-9. PubMed ID: 7912298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspects.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Kimoto M; Kawakami S; Miyoshi H; Kubozono O
    Dig Dis Sci; 1991 Jun; 36(6):780-4. PubMed ID: 1827761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y
    Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor.
    Strain AJ; Neuberger JM
    Gut; 1992 Feb; 33(2):286-7. PubMed ID: 1531802
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
    Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure.
    Gohda E; Yamasaki T; Tsubouchi H; Kurobe M; Sakiyama O; Aoki H; Niidani N; Shin S; Hayashi K; Hashimoto S
    Biochim Biophys Acta; 1990 Jun; 1053(1):21-6. PubMed ID: 2142004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.
    LeCouter J; Moritz DR; Li B; Phillips GL; Liang XH; Gerber HP; Hillan KJ; Ferrara N
    Science; 2003 Feb; 299(5608):890-3. PubMed ID: 12574630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.
    Ljubimova JY; Petrovic LM; Arkadopoulos N; Blanc P; Geller SA; Demetriou AA
    Dig Dis Sci; 1997 Aug; 42(8):1675-80. PubMed ID: 9286233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.
    Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R
    J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor.
    Michalopoulos GK; Zarnegav R
    Hepatology; 1992 Jan; 15(1):149-55. PubMed ID: 1530787
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy.
    Margeli AP; Manolis E; Skaltsas SN; Tsarpalis KS; Mykoniatis MG; Theocharis SE
    Dig Dis Sci; 2002 Oct; 47(10):2170-8. PubMed ID: 12395888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators, cytokines, and growth factors in liver-lung interactions.
    Panos RJ; Baker SK
    Clin Chest Med; 1996 Mar; 17(1):151-69. PubMed ID: 8665787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. Basic aspects.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Arakaki N; Yamamoto I; Hashimoto S; Daikuhara Y
    Dig Dis Sci; 1991 Jun; 36(6):785-90. PubMed ID: 1827762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteolytic cascade for activation of hepatocyte growth factor in response to tissue injury].
    Miyazawa K; Shimomura T
    Seikagaku; 1995 May; 67(5):381-5. PubMed ID: 7602213
    [No Abstract]   [Full Text] [Related]  

  • 17. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z; Nagy P
    Orv Hetil; 2004 Aug; 145(35):1787-93. PubMed ID: 15493221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure.
    Hughes RD; Yamada H; Gove CD; Williams R
    Dig Dis Sci; 1991 Jun; 36(6):816-9. PubMed ID: 2032522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scatter factor and its relationship to hepatocyte growth factor and met.
    Rosen EM; Knesel J; Goldberg ID
    Cell Growth Differ; 1991 Nov; 2(11):603-7. PubMed ID: 1839956
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological approach to impaired liver regeneration in fulminant hepatic failure.
    Ohnishi H; Muto Y
    Trop Gastroenterol; 1993; 14(4):127-31. PubMed ID: 8171726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.